Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Altimmune Inc. ALT

Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH (non-alcoholic steatohepatitis). In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B virus (HBV).

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:ALT)

Fundamentals Snapshot (NDAQ:ALT)

Opinion & Analysis (NDAQ:ALT)

No current opinion is available.

Bullboard Posts (NDAQ:ALT)

Can the President Overrule the FDA on Vaccines?

An approval cycle that typically takes years is being expedited. In the case of the 2020 pandemic, the FDA  has shortened standard...
schoolofrock - October 7, 2020

no and no

NO CURE FOR CANCER since 1981 https://en.wikipedia.org/wiki/Terry_Fox_Run NO CURE FOR HIV https://www.hiv.gov/hiv-basics/hiv...
starman1975 - May 26, 2020

I can’t get over today’s volume!

Can someone explain to me how this stock went from 49.00 down to 1.70 in a year? They seem to have lots of cash on hand as well.
SeekAlpha81 - March 19, 2019

breakout alert for this one

it's going up big time,so glta shareholders.
coolfooldumbguy - March 19, 2019

RE:Well some News is out get on board

https://clinicaltrials.gov/ct2/show/NCT03760549?term=nasoVAX&rank=1
MrMikeTriumph - March 7, 2019

ALT Altimmune is the correct symbol

stockhouse stinks with the symbols 
coolfooldumbguy - March 7, 2019